bNAbs Delay HIV Viral Rebound in RIO Trial: Phase 2 Results
Published in Nature Medicine, findings from the phase 2 RIO trial reveal that adult males living with HIV who received broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS experienced delayed viral rebound … Read More